RENAISSANCE TECHNOLOGIES LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1037389 NEW YORK, NY

Position in FTRE

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$13,496,118

-$126,362 QoQ

Shares Held

1,432,709

+81.4% QoQ

Ownership

1.51%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,464,545,054 across 328 Biotechnology names. FTRE ranks #38 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,496,118	1,432,709	+81.4%	Shares	Sole	2026-05-14
2025-12-31	$13,622,480	789,709	-39.0%	Shares	Sole	2026-02-12
2025-09-30	$10,903,900	1,295,000	+118.5%	Shares	Sole	2025-11-13
2025-06-30	$2,927,444	592,600	+53.7%	Shares	Sole	2025-08-13
2025-03-31	$2,910,525	385,500	+19.7%	Shares	Sole	2025-05-14
2024-12-31	$6,004,964	321,982	+2996.0%	Shares	Sole	2025-02-13
2024-09-30	$208,000	10,400	-96.5%	Shares	Sole	2024-11-13
2024-06-30	$6,899,304	295,600	-30.6%	Shares	Sole	2024-08-09
2024-03-31	$17,107,668	426,200	+70.6%	Shares	Sole	2024-05-13
2023-12-31	$8,718,020	249,800	+801.8%	Shares	Sole	2024-02-13
2023-09-30	$791,943	27,700	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.